1. Home
  2. PGEN vs KELYB Comparison

PGEN vs KELYB Comparison

Compare PGEN & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • KELYB
  • Stock Information
  • Founded
  • PGEN 1998
  • KELYB 1946
  • Country
  • PGEN United States
  • KELYB United States
  • Employees
  • PGEN N/A
  • KELYB N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • KELYB Professional Services
  • Sector
  • PGEN Health Care
  • KELYB Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • KELYB Nasdaq
  • Market Cap
  • PGEN 493.0M
  • KELYB 483.4M
  • IPO Year
  • PGEN N/A
  • KELYB N/A
  • Fundamental
  • Price
  • PGEN $3.82
  • KELYB $13.84
  • Analyst Decision
  • PGEN Buy
  • KELYB
  • Analyst Count
  • PGEN 5
  • KELYB 0
  • Target Price
  • PGEN $7.50
  • KELYB N/A
  • AVG Volume (30 Days)
  • PGEN 9.2M
  • KELYB 155.0
  • Earning Date
  • PGEN 11-13-2025
  • KELYB 11-06-2025
  • Dividend Yield
  • PGEN N/A
  • KELYB 2.08%
  • EPS Growth
  • PGEN N/A
  • KELYB N/A
  • EPS
  • PGEN N/A
  • KELYB N/A
  • Revenue
  • PGEN $4,340,000.00
  • KELYB $4,495,900,000.00
  • Revenue This Year
  • PGEN $253.63
  • KELYB $6.05
  • Revenue Next Year
  • PGEN $699.64
  • KELYB $4.18
  • P/E Ratio
  • PGEN N/A
  • KELYB N/A
  • Revenue Growth
  • PGEN N/A
  • KELYB 0.97
  • 52 Week Low
  • PGEN $0.65
  • KELYB $11.04
  • 52 Week High
  • PGEN $5.23
  • KELYB $21.22
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 54.30
  • KELYB 52.45
  • Support Level
  • PGEN $3.47
  • KELYB $14.00
  • Resistance Level
  • PGEN $4.14
  • KELYB $15.05
  • Average True Range (ATR)
  • PGEN 0.35
  • KELYB 0.00
  • MACD
  • PGEN -0.16
  • KELYB -0.10
  • Stochastic Oscillator
  • PGEN 19.89
  • KELYB 14.61

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: